DVANYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
DAVITA INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$187.00−0.31 (-0.17%)
Close on Oct 19, 2026
- Market cap
- $12.36B
- P/E (TTM)
- 15.3
- Dividend yield
- –
DAVITA INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Operating Segments with Intersegment | $2.08B | $2.01B | $1.92B | $1.79B | $1.71B | $1.58B | $1.51B | – | – | – | – | – | 14.8% | +21.6% |
| Other - Ancillary Services | $2.06B | $1.99B | $1.91B | $1.77B | $1.69B | $1.57B | $1.50B | $1.43B | $1.42B | $1.35B | $1.29B | $1.21B | 14.7% | +21.8% |
| U S Dialysis | – | – | – | – | – | $11.37B | $11.32B | $11.20B | $11.08B | $10.97B | $10.85B | $10.79B | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other - Ancillary Services | $101.36M | $101.02M | $92.38M | $153.97M | $166.66M | $91.35M | $82.66M | -$6.56M | $7.63M | $4.62M | -$8.75M | -$58.26M | -39.2% |
| U S Dialysis | – | – | – | – | – | $2.07B | $2.12B | $2.07B | $2.03B | $1.94B | $1.77B | $1.67B | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Davita's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.